首页> 外文期刊>Journal of general internal medicine >Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
【24h】

Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.

机译:在实现胆固醇治疗目标方面存在种族差异。使用新型电子技术的国家胆固醇教育计划评估项目的结果II。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: African Americans (AA) have the highest coronary heart disease mortality rate of any ethnic group in the United States. Data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey were used to assess ethnic differences in low-density lipoprotein cholesterol (LDL-C) goal achievement. METHODS: NEPTUNE II surveyed patients with treated dyslipidemia to assess achievement of treatment goals established by the Adult Treatment Panel III of the National Cholesterol Education Program. United States physicians working in primary care or relevant subspecialties enrolled 10 to 20 consecutive patients (May to September 2003), and patient data were recorded in Personal Digital Assistants and uploaded to a central database via the internet. RESULTS: Among 4,885 patients receiving treatment for dyslipidemia, 79.7% were non-Hispanic white (NHW) and 8.4% were AA. Non-Hispanic white and AA patients had significantly different frequencies of treatment success, with 69.0% and 53.7%, respectively, having achieved their LDL-C goal (P<.001). African-American patients were more likely to be in the highest risk category, and less likely to be using lipid drug therapy, taking high-efficacy statins, and receiving care from a subspecialist, but the difference in goal achievement remained significant (P<.001) after adjustment for these and other predictors of treatment success. CONCLUSIONS: The frequency of treatment success in dyslipidemia management was significantly lower in AA than NHW patients. Additional research is needed to elucidate reasons for this disparity and to evaluate strategies for improving goal achievement among AA patients receiving therapy for dyslipidemia.
机译:背景:非裔美国人(AA)的冠心病死亡率是美国所有种族中最高的。来自国家胆固醇教育计划利用新型电子技术的评估项目(NEPTUNE)II调查的数据用于评估低密度脂蛋白胆固醇(LDL-C)目标实现中的种族差异。方法:NEPTUNE II对接受治疗的血脂异常患者进行了调查,以评估由国家胆固醇教育计划的成人治疗小组III确定的治疗目标的实现情况。在基层医疗或相关亚专业工作的美国医生连续招募了10至20位患者(2003年5月至2003年9月),患者数据记录在Personal Digital Assistants中,并通过互联网上传到中央数据库。结果:在接受血脂异常治疗的4,885例患者中,非西班牙裔白人(NHW)占79.7%,AA占8.4%。非西班牙裔白人和AA患者的治疗成功率显着不同,分别达到LDL-C目标的概率分别为69.0%和53.7%(P <.001)。非裔美国人患者更有可能属于最高风险类别,不太可能使用脂质药物治疗,服用高效他汀类药物并接受专科医生治疗,但目标达成的差异仍然很大(P <。 001)针对这些和其他预测治疗成功的因素进行调整后。结论:AA患者血脂异常治疗成功率明显低于NHW患者。需要进一步的研究来阐明这种差异的原因,并评估在接受血脂异常治疗的AA患者中改善目标达成的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号